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Abstract
Introduction
Clinical genomics promise to be especially suitable for the study of etiologically heteroge-
neous conditions such as Autism Spectrum Disorder (ASD). Here we present three siblings
with ASD where we evaluated the usefulness of Whole Genome Sequencing (WGS) for the
diagnostic approach to ASD.
Methods
We identified a family segregating ASD in three siblings with an unidentified cause. We per-
formedWGS in the three probands and used a state-of-the-art comprehensive bioinformatic
analysis pipeline and prioritized the identified variants located in genes likely to be related to
ASD. We validated the finding by Sanger sequencing in the probands and their parents.
Results
Three male siblings presented a syndrome characterized by severe intellectual disability,
absence of language, autism spectrum symptoms and epilepsy with negative family history
for mental retardation, language disorders, ASD or other psychiatric disorders. We found
germline mosaicism for a heterozygous deletion of a cytosine in the exon 21 of the SHANK3
gene, resulting in a missense sequence of 5 codons followed by a premature stop codon
(NM_033517:c.3259_3259delC, p.Ser1088Profs*6).
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Conclusions
We reported an infrequent form of familial ASD where WGS proved useful in the clinic. We
identified a mutation in SHANK3 that underscores its relevance in Autism Spectrum Disorder.
Introduction
Autism spectrum disorder (ASD) is a common cause of early disability, affecting about 1% of
the population. It is characterized by impairments in social interaction and communication, as
well as by repetitive and restricted behaviors [1].
ASD is etiologically heterogeneous, with hundreds of highly penetrant genetic aberrations
involved as causative factors. Among them, SHANK3 haploinsufficiency has been identified in
about 0.5% of subjects with ASD. However, few familial ASD cases caused by mutations in
SHANK3 have been identified [2]. Here we present three siblings with ASD where Whole Ge-
nome Sequencing (WGS), identified germline mosaicism for a new mutation in SHANK3.
Methods
Study participants
The Ethics Committee of Hospital Ramos Mejía in Buenos Aires, Argentina approved this
study. Written informed consents were obtained from the parents of the probands. Clinical in-
vestigation was conducted according to the principles expressed in the Declaration of Helsinki.
The parents of the individuals described in this manuscript gave written informed consent to
publish these case details. DNA sequencing data remained stored in a secure internal database,
and is available upon request to researchers wishing to use them for research purposes only.
Clinical evaluations were performed at the Neurogenetics Unit from Hospital Ramos Mejía.
Genome sequence data generation
Genomic DNA was isolated from peripheral blood and sequenced using 101 base-pair paired-
end reversible terminator massively parallel sequencing on an Illumina Hiseq 1500 instrument
at INDEAR (Rosario, Argentina), following sequencing library preparation in agreement to
standard Illumina protocols. Median fragment length of the libraries was 294 bp. A total of
334.1 Gb with quality equal or more than Q30 was produced for the three genomes. Specifical-
ly, 575,427,640 paired-end reads were produced for proband 1 (35.5X coverage), 603,002,568
paired-end reads were produced for proband 2 (37.18X coverage) and 527,754,644 paired-end
reads were produced for proband 3 (32.58X coverage).
Sequence Alignment and Annotation
Paired-end reads obtained from sequencing the probands’ whole genomes were aligned to the
GRCh37 reference human genome using the Burrows-Wheeler Alignment Tool (BWA) [3]. The
resulting SAM files were realigned and recalibrated by implementation of the Genome Analysis
Toolkit (GATK) framework [4,5]. Variant calling was performed using the Unified Genotyper
tools from GATK. Variant annotation and effect prediction was carried out with SnpEff 3.5a
(build 2014-02-14) [6,7] with data from dbSNP Build 138 [8], the 1000 Genomes Project [9], the
International HapMap Project [10], the NHGRI GWAS Catalog [11], dbNSFP v2.3 [12,13], the
Exome Sequencing Project (ESP) [14], and ClinVar Build 20140211 [15]. See S1 Fig.
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Bioinformatic Prioritization of candidate variants (see Table 1)
Only high-quality variants (i.e. not filtered out by the GATK’s Variant Quality Score Recalibra-
tion method) were considered for the analysis. Those with recorded population frequencies es-
timates higher than 1% (data from the 1000 Genomes Project and the Exome Sequencing
Project) were also discarded as unlikely to be of relevance. From this remaining set, variants
with high probability of affecting gene function (frame-shift, nonsense, missense, affecting
splice sites and small insertions and deletions) were grouped according to 3 different models of
inheritance that may explain the probands’ phenotype: a recessive model grouped homozygous
variants or compound heterozygous candidate variants present in the somatic chromosomes, a
X-linked model grouped variants from the X chromosome, and a high impact and rare variants
model grouped only high impact (nonsense, frame-shift, splice site changes) variants not re-
corded in the available databases. These groups were filtered through a list of 182 genes known
to be of relevance in ASD according to SFARI database [16] (S1 Table).
Manual Review of Candidate variants
After prioritization, variants considered to possibly explain the phenotype were further investi-
gated individually through the use of several databases and functional evaluation tools which
included those provided by NCBI (www.ncbi.nlm.nih.gov), ENSEMBL [17] (www.ensembl.
org/index.html), Mutation Taster [18] (www.mutationtaster.org), the Combined Annotation
Dependent Depletion framework [19] (cadd.gs.washington.edu) and the Search Tool for the
Retrieval of Interacting Genes/Proteins [20] (STRING; string-db.org), among others.
Table 1. Summary of variants in the 3 genomes.
Proband 1
(III-1)
Proband 2
(III-2)
Proband 3
(III-3)
Shared
Reads 1,150,855,280 1,206,005,136 1,055,509,288 -
High Conﬁdence (HC) Variants 4,157,729 4,152,776 4,155,158 3,153,415
HC Variants in Coding Regions* 24,319 23,882 23,939 18,394
HC Variants at Splice sites** 467 450 447 351
HC Single Nucleotide Variants (SNV) 3,556,615 3,547,621 3,543,994 2,750,765
HC Short Indels 601,114 605,155 611,164 402,650
HC Variants in ASD gene’s list 71,348 69,173 69,215 53,358
HC Variants compliant to the Recessive Model 438 395 394 145
Genes with HC variants compliant to the Recessive Model 207 198 194 86
HC Variants in in ASD genes and compliant with the Recessive Model 2 1 1 1
ASD genes with HC Variants compliant with the Recessive Model 2 1 1 1
HC Variants compliant to the X-Linked Model 16 11 10 5
Genes with HC variants compliant to the X-Linked Model 14 10 9 4
HC Variants in in ASD genes and compliant with the X-Linked Model 1 0 0 0
ASD genes with HC Variants compliant with the X-Linked Model 1 0 0 0
HC Variants compliant to the High Impact De Novo Model 24 35 28 6
Genes with HC variants compliant to the High Impact De Novo Model 23 35 27 6
HC Variants in ASD genes and compliant with the High Impact De Novo Model 1 1 1 1
ASD genes with HC Variants compliant with the High Impact De Novo Model 1 1 1 1
* Including all changes withing coding regions (synonymous and nonsynonymous substitutions and short insertions and deletions)
** Deﬁned as 2 bases after exon end or 2 bases before exon start (only measured in introns).
doi:10.1371/journal.pone.0116358.t001
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Results
Case Descriptions
Three male siblings were included in this study. All of them presented a syndrome character-
ized by severe intellectual disability, absence of language, autism spectrum symptoms and epi-
lepsy. Family history was otherwise negative for mental retardation, language disorders, ASD
or other psychiatric disorders. They were the sole offspring of healthy and unrelated parents
after full-term and uneventful pregnancies (Fig. 1A). The mother performed appropriate health
checks during gestations and she didn’t show any pathological findings. Deliveries and birth
parameters were unremarkable. The eldest proband (III-1 in Fig. 1A) was symptomatic since
birth. Neonatal hypotonia was manifested by sucking difficulties and a mild delay in motor de-
velopment. He had limited eye contact since 6 months of age. He never developed a functional
language. He showed severe behavioral problems, motor stereotypes and circumscribed inter-
ests since the age of four. He developed epilepsy at the age of 6, suffering from frequent atonic
seizure non-respondent to classical antiepileptic drugs. The younger siblings (III-2 and III-3)
showed very similar clinical features. They shared dysmorphic features: broad nasal bridge,
bulbous nasal root and macrostomia. They exhibited no neonatal hypotonia and showed nor-
mal development during their first two years of life with no observable alterations in language.
A progressive deterioration started after this age. Language development was arrested, evolving
Figure 1. A SHANK3 point mutation in three siblings with Autism Spectrum Disorder. A) Family
pedigree depicting the three probands (III-1, III-2, III-3), parents, their siblings and grandparents. B) Mutation
as evidenced by whole genome sequencing compared to reference sequence (GRCh37) at bottom. Broad
lines represent aligned reads. The heterozygous deletion is depicted as black, thin lines that interrupt the
reads. Each panel depicts the data from one proband, C) Capillary sequencing chromatograms of the
probands and their parents. A red arrow signals the position of the deletion. The change in ORF is evidenced
by the presence of double peaks after the deletion site caused by heterozygocity. D) Linear representations
of the intact SHANK3 protein featuring its major domains and the presumptive protein if translated from the
mutated sequence. ANK: ankyrin repeats, SH3: SRC Homology 3 domain, PDZ: PDZ domain, Pro: Proline-
rich region, SAM: Sterile alpha motif domain.
doi:10.1371/journal.pone.0116358.g001
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to an almost complete absence of verbal communication. Social interaction became severely
impaired. Agitation and repetitive motor behaviors were present since the age of three. Epilep-
sy with frequent atonic and generalized seizures refractory to medical treatment started at the
age of 7 in both siblings. MRIs were normal and some of the several EEGs done showed right-
temporal discharges. Standard karyotype and fragile X testing were normal in the three
siblings.
Whole Genome Analysis
We performed whole genome sequencing of DNA samples from the three siblings, obtaining a
mappable yield of 334.1 Gb, which represent an average depth of coverage of 33.04x. We iden-
tified more than 4.1 millions of variants in each genome (Table 1). We examined those rare
variants (population frequency lower than 1%) in 182 genes associated to ASD (S1 Table)
under three possible models of inheritance: recessive, X-linked, high impact de novo mutations
(S2 Table, S3 Table). The most plausible candidate to explain the phenotype exhibited by the
probands was a heterozygous deletion of a cysteine in the exon 21 of the SHANK3 gene
(Fig. 1, B), resulting in a missense sequence of 5 codons followed by a premature stop codon
(NM_033517:c.3259_3259delC, p.Ser1088Profs6). We did not find any difference in SHANK3
mRNA levels in blood among the three affected siblings, their parents and two unrelated
controls, suggesting an absence of effect at the transcription level. Therefore, when expressed
this protein would lack a Proline-rich region and the Sterile alpha motif (SAM) domain
(Fig. 1, D) resulting in a functional haploinsufficiency of SHANK3 protein. Sanger sequencing
confirmed this deletion in the three siblings and their absence in DNA purified from
blood samples of both parents suggesting germinal mosaicism as the origin of the mutation
(Fig. 1, C).
Discussion
Gene mutations can be identified in about 20% of individuals with ASD [21]. SHANK3 aberra-
tions have consistently been associated with idiopathic and syndromic ASD. However, point
mutations in SHANK3 have been rarely reported. A few patients were previously described
with only one showing familial recurrence. It has been suggested that nonsense and frameshift
mutations in this gene lead to more severe phenotypes [22] affecting language and develop-
ment as it was observed in our patients. Moreover, a recent and exhaustive report on the effect
of different mutations in the SHANK family of genes in ASD concluded that SHANK3muta-
tions are probably the most prevalent etiology of ASD with mental retardation and among the
different cases described there it is noteworthy to highlight one that have a frameshift deletion
predicted to result in a truncated protein lacking the same functional domains that we predict
for our mutation, thereby supporting a pathogenic role for the variant here described, preclud-
ing the need for more thorough functional assays [23]. The product of this gene is expressed at
postsynaptic densities of excitatory glutamatergic synapses and it is involved in synaptic matu-
ration [24]. Moreover, pharmacological restoring of its deficiency is current object of therapeu-
tic research in ASD [25].
The use of WGS in the clinic is called to be transformative, especially in a complex etiologi-
cally heterogeneous disorder such as ASD and intellectual disability [26]. However, recent
studies have questioned its readiness for diagnostic adoption mostly because of uncertainties
associated with the analysis of such vast amount of information [27]. We have ruled out many
variants with a predicted high-impact on protein function because we opted to focus our analy-
sis on genes considered to be of relevance for the phenotype studied therefore decreasing inter-
pretation uncertainties. This left the reported SHANK3mutation as the sole variant putatively
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relevant to the phenotype showed in our patients. It is noteworthy to mention that by identify-
ing the pathogenic variant causing the disorder segregating in this family, almost a decade of
anxiety associated with diagnostic uncertainties could be alleviated. However, even though we
could explain the recurrence of the disorder in the three siblings with the presence of germline
mosaicism we could not estimate future recurrence risk because the proportion of germ cells
mutated could not be quantified.
In summary, we reported an infrequent form of familial ASD where WGS proved useful in
the clinic.
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S1 Fig. Flow diagram of the analysis. Reads resulting fromWhole Genome Sequencing were
aligned to the reference genome (GRCh37) with BWA and followed by realignment and recali-
bration with the Genome Analysis Toolkit (GATK). Variant calling was performed with the
Unified Genotyper tool from the GATK, and annotated with SnpEff (see S1 Methods). After
the whole variants set was produced, variants shared by the 3 probands were filtered if they
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